InterAct Consortium
United Kingdom (UK)
1 July 2019 - 30 June 2020
Research collaboration: InterAct Consortium is a research collaboration whose article contributions are accrued to its participating partner institutions.
InterAct Consortium
Partner Institutions
InterAct Consortium is a research collaboration whose article contributions are accrued to its participating partner institutions below.
- Danish Cancer Society, Denmark
- Steno Diabetes Center A/S, Denmark
- Aalborg University Hospital, Denmark
- University of Helsinki, Finland
- University of Kuopio, Finland
- WHO International Agency for Research on Cancer (IARC), France
- National Institute for Health and Medical Research (INSERM), France
- German Cancer Research Center in the Helmholtz Association (DKFZ), Germany
- Leibniz German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), Germany
- Cancer Research and Prevention Institute (ISPO), Italy
- National Cancer Institute of Milan, Italy
- University of Naples Federico II (UNINA), Italy
- Institute for Scientific Interchange (ISI), Italy
- Azienda Ospedaliera Civile M.P. Arezzo, Italy
- Wageningen University & Research (WUR), Netherlands
- University Medical Center Utrecht (UMC Utrecht), Netherlands
- National Institute for Public Health and the Environment (RIVM), VWS, Netherlands
- Andalusian School of Public Health (EASP), UGR, Spain
- Catalan Institute of Oncology (ICO), Spain
- Lund University (LU), Sweden
- Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), United Kingdom (UK)
- Imperial College London (ICL), United Kingdom (UK)
- University of Oxford, United Kingdom (UK)
- Wellcome Sanger Institute, United Kingdom (UK)
- India Diabetes Research Foundation (IDRF), India
- University Hospital of Umeå (NUS), Sweden
- MRC Epidemiology Unit, University of Cambridge, United Kingdom (UK)
- Healthcare Research Institute of Navarre (IdiSNA), Spain
